We are live on
!
Find out more
MSL
Mackay Shields LLC Portfolio holdings
AUM
$2.73B
1-Year Est. Return
2.13%
This Fund
S&P 500
This Quarter
Est. Return
+0.7%
1 Year Est. Return
+2.13%
3 Year Est. Return
+7.81%
5 Year Est. Return
+19%
10 Year Est. Return
+113.23%
AUM
$10.6B
AUM Growth
-$29M
(-0.27%)
Cap. Flow
-$2.95B
Cap. Flow
% of AUM
-27.83%
Top 10 Holdings %
Top 10 Hldgs %
25.65%
Holding
722
New
10
Increased
39
Reduced
477
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$19.8M |
| 2 |
TSMC
TSM
|
+$10.7M |
| 3 |
Match Group
MTCH
|
+$6.4M |
| 4 |
Vistra
VST
|
+$5.66M |
| 5 |
CPLB
NYLI MacKay Core Plus Bond ETF
CPLB
|
+$4.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$36.4M |
| 2 |
Microsoft
MSFT
|
+$10.8M |
| 3 |
Apple
AAPL
|
+$10.4M |
| 4 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$6.41M |
| 5 |
Nuveen AMT-Free Quality Municipal Income Fund
NEA
|
+$6.18M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.42% |
| 2 | Financials | 7.36% |
| 3 | Healthcare | 6.77% |
| 4 | Consumer Discretionary | 6.29% |
| 5 | Communication Services | 5.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
551
Vistra
VST
$55.1B
| $14K | ﹤0.01% |
319,975
+306,057
| +2,199% | +$5.66M |
|
|
DMB
552
BNY Mellon Municipal Bond Infrastructure Fund
DMB
$197M
| – | – |
-50,575
| Closed | -$743K |
|
|
EMD
553
Western Asset Emerging Markets Debt Fund
EMD
$609M
| – | – |
-13,258
| Closed | -$186K |
|
554
NOV
NOV
$7.45B
| – | – |
-60,397
| Closed | -$925K |
|
|
PMO
555
Franklin Municipal Opportunities Trust
PMO
$287M
| – | – |
-134,024
| Closed | -$1.9M |
|
556
Unum
UNM
$13.8B
| – | – |
-31,447
| Closed | -$893K |
|
557
Invesco Trust Investment Grade Municipals
VGM
$549M
| – | – |
-77,998
| Closed | -$1.09M |
|
558
Invesco Advantage Municipal Income Trust II
VKI
$394M
| – | – |
-112,398
| Closed | -$1.37M |
|
559
Invesco Municipal Trust
VKQ
$536M
| – | – |
-38,647
| Closed | -$530K |
|
|
WIW
560
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$510M
| – | – |
-14,400
| Closed | -$189K |
|
|
MXIM
561
DELISTED
Maxim Integrated Products
MXIM
| – | – |
-42,291
| Closed | -$4.46M |
|
|
ALXN
562
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-34,871
| Closed | -$6.41M |
|
Similar funds
GC
PA
MASUI
LMIM
XL
PCM
CIAS
CA
Mackay Shields LLC's Q3 2021 Portfolio in Review
As of Q3 2021, Mackay Shields LLC held 722 positions worth $10.6B, down 0.27% from $10.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Mackay Shields LLC withdrew a net $2.95B in Q3 2021, closing 11 positions and reducing 477 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $6.41M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Mackay Shields LLC opened a new position in Moderna worth $20.7M.
- Mackay Shields LLC's largest Q3 2021 buy was Moderna: 53,663 shares worth $20.7M.
- Mackay Shields LLC added most to TSMC in Q3 2021, an estimated $10.7M increase.
- Mackay Shields LLC's biggest Q3 2021 reduction was Lam Research, cutting an estimated $36.4M.
- Mackay Shields LLC fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $6.41M.
- Mackay Shields LLC's ten largest holdings make up 26% of its $10.6B portfolio in Q3 2021.
- Mackay Shields LLC opened 10 new positions and closed 11 in Q3 2021.
- Mackay Shields LLC's portfolio value fell 0.27% quarter-over-quarter to $10.6B.
Based on Mackay Shields LLC's 13F filing for Q3 2021, filed 12 Nov 2021.